Viking Therapeutics saw the highest growth of 1.99% in patent filings in May and 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Viking Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Viking Therapeutics has been focused on protecting inventions in South Korea(KR) with two publications in Q2 2024
The South Korea(KR) Patent Office dominates the patent filings with nearly 29% of filings. The South Korea(KR), United States(US), Argentina(AR), and Australia(AU) patent Office are among the top ten patent offices where Viking Therapeutics is filings its patents. Among the top granted patent authorities, Viking Therapeutics has 100% of its grants in United States(US).
Gilead Sciences could be the strongest competitor for Viking Therapeutics
Patents related to rare diseases lead Viking Therapeutics's portfolio
Viking Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Fibrosis related patents lead Viking Therapeutics portfolio followed by atherosclerosis, and adrenomyeloneuropathy (amn)
Viking Therapeutics has highest number of patents in fibrosis followed by atherosclerosis, adrenomyeloneuropathy (amn), dupuytren contracture, and dermatomyositis.
For comprehensive analysis of Viking Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
